Glial hemichannels and their involvement in aging and neurodegenerative diseases

Reviews in the Neurosciences

Volumn 23, Issue 2, 2012, Pages 163-177

  Orellana, Juan A ^a   Von Bernhardi, Rommy ^a   Giaume, Christian ^b,c   Sáez, Juan C ^d,e  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b l'alimentation et l'Environnement   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^e Centro Interdisciplinario de Neurociencias de Valparaíso   (Chile)

Author keywords

astrocytes; brain; connexins; inflammation; microglia; pannexins

Indexed keywords

ADENOSINE TRIPHOSPHATE; CANNABINOID; GAP JUNCTION PROTEIN; GLUTAMIC ACID; INTERLEUKIN 1BETA; PANNEXIN; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGING; ASTROCYTE; AUTOCRINE EFFECT; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL COMMUNICATION; CELL MEMBRANE PERMEABILITY; CYTOKINE RELEASE; DEGENERATIVE DISEASE; ENDOTHELIUM; EXCITOTOXICITY; EXTRACELLULAR SPACE; GAP JUNCTION; HUMAN; IMMUNOTHERAPY; INTRACELLULAR SPACE; MICROGLIA; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYNAPTIC TRANSMISSION;

ADENOSINE TRIPHOSPHATE; AGING; ASTROCYTES; CALCIUM; CANNABINOIDS; CENTRAL NERVOUS SYSTEM; CONNEXIN 43; CONNEXINS; DINOPROSTONE; GLUCOSE; GLUTAMIC ACID; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; ION CHANNELS; NAD; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; OLIGODENDROGLIA; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861088488     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro-2011-0065     Document Type: Review

References (173)

1. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., Cooper, N.R., Eikelenboom, P., Emmerling, M., Fiebich, B.L., et al. (2000). Inflammation and Alzheimer's disease. Neurobiol. Aging 21 , 383-421.
2. Al-Ubaidi, M.R., White, T.W., Ripps, H., Poras, I., Avner, P., Gomes, D., and Bruzzone, R. (2000). Functional properties, developmental regulation, and chromosomal localization of murine connexin36, a gap-junctional protein expressed preferentially in retina and brain. J. Neurosci. Res. 59 , 813-826.
3. Alarcón, R., Fuenzalida, C., Santibanez, M., and von Bernhardi, R. (2005). Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound β-amyloid. J. Biol. Chem. 280 , 30406-30415.
4. Baker, D., Pryce, G., Croxford, J.L., Brown, P., Pertwee, R.G., Huffman, J.W., and Layward, L. ( 2000). Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 404 , 84-87.
5. Bao, L., Locovei, S., and Dahl, G. (2004). Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett. 572 , 65-68.
6. Benito, C., Nuñez, E., Tolon, R.M., Carrier, E.J., Rabano, A., Hillard, C.J., and Romero, J. (2003). Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J. Neurosci. 23 , 11136-11141.
7. Block, M.L., Zecca, L., and Hong, J.S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8 , 57-69.
8. Bruzzone, R., Hormuzdi, S.G., Barbe, M.T., Herb, A., and Monyer, H. (2003). Pannexins, a family of gap junction proteins expressed in brain. Proc. Natl. Acad. Sci. USA 100 , 13644-13649.
9. Bruzzone, S., Guida, L., Zocchi, E., Franco, L., and De Flora, A. (2001). Connexin 43 hemi channels mediate Ca 2 +-regulated transmembrane NAD βfluxes in intact cells. FASEB J. 15 , 10-12.
10. Burra, S. and Jiang, J.X. (2009). Connexin 43 hemichannel opening associated with Prostaglandin E 2 release is adaptively regulated by mechanical stimulation. Commun. Integr. Biol. 2 , 239-240.
11. Bye, N., Zieba, M., Wreford, N.G., and Nichols, N.R. (2001). Resistance of the dentate gyrus to induced apoptosis during ageing is associated with increases in transforming growth factor-β1 messenger RNA. Neuroscience 105 , 853-862.
12. Byrnes, K.R., Loane, D.J., and Faden, A.I. (2009). Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics 6 , 94-107.
13. Cabral, G.A. and Griffin-Thomas, L. (2008). Cannabinoids as therapeutic agents for ablating neuroinflammatory disease. Endocr. Metab. Immune Disord. Drug Targets 8 , 159-172.
14. Carmen, J., Gowing, G., Julien, J.P., and Kerr, D. (2006). Altered immune response to CNS viral infection in mice with a conditional knock-down of macrophage-lineage cells. Glia 54 , 71-80.
15. Carson, M.J., Doose, J.M., Melchior, B., Schmid, C.D., and Ploix, C.C. (2006). CNS immune privilege: hiding in plain sight. Immunol. Rev. 213 , 48-65.
16. Cherian, P.P., Siller-Jackson, A.J., Gu, S., Wang, X., Bonewald, L.F., Sprague, E., and Jiang, J.X. (2005). Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol. Biol. Cell 16 , 3100-3106.
17. Cina, C., Bechberger, J.F., Ozog, M.A., and Naus, C.C. (2007). Expression of connexins in embryonic mouse neocortical development. J. Comp. Neurol. 504 , 298-313.
18. Coffey, R.G., Snella, E., Johnson, K., and Pross, S. (1996). Inhibition of macrophage nitric oxide production by tetrahydrocannabinol in vivo and in vitro . Int. J. Immunopharmacol. 18 , 749-752.
19. Contreras, J.E., Sánchez, H.A., Eugenín, E.A., Speidel, D., Theis, M., Willecke, K., Bukauskas, F.F., Bennett, M.V., and Sáez, J.C. (2002). Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc. Natl. Acad. Sci. USA 99 , 495-500.
20. Contreras, J.E., Sánchez, H.A., Veliz, L.P., Bukauskas, F.F., Bennett, M.V., and Sáez, J.C. (2004). Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res. Brain Res. Rev. 47 , 290-303.
21. Cotrina, M.L., Lin, J.H., and Nedergaard, M. (2008). Adhesive properties of connexin hemichannels. Glia 56 , 1791-1798.
22. Croxford, J.L. (2003). Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 17 , 179-202.
23. Croxford, J.L., Pryce, G., Jackson, S.J., Ledent, C., Giovannoni, G., Pertwee, R.G., Yamamura, T., and Baker, D. (2008). Cannabinoidmediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis. J. Neuroimmunol. 193 , 120-129.
24. Cruciani, V. and Mikalsen, S.O. (2005). The connexin gene family in mammals. Biol. Chem. 386 , 325-332.
25. Dahl, G. (2007). Gap junction-mimetic peptides do work, but in unexpected ways. Cell Commun. Adhes. 14 , 259-264.
26. Dermietzel, R., Traub, O., Hwang, T.K., Beyer, E., Bennett, M.V., Spray, D.C., and Willecke, K. (1989). Differential expression of three gap junction proteins in developing and mature brain tissues. Proc. Natl. Acad. Sci. USA 86 , 10148-10152.
27. DeWitt, D.A., Perry, G., Cohen, M., Doller, C., and Silver, J. (1998). Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149 , 329-340.
28. Dodart, J.C., Bales, K.R., Gannon, K.S., Greene, S.J., DeMattos, R.B., Mathis, C., DeLong, C.A., Wu, S., Wu, X., Holtzman, D.M., et al. (2002). Immunization reverses memory deficits without reducing brain A βburden in Alzheimer's disease model. Nat. Neurosci. 5 , 452-457.
29. Domercq, M., Perez-Samartin, A., Aparicio, D., Alberdi, E., Pampliega, O., and Matute, C. (2010). P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 58 , 730-740.
30. Ethell, D.W., Shippy, D., Cao, C., Cracchiolo, J.R., Runfeldt, M., Blake, B., and Arendash, G.W. (2006). A β-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice. Neurobiol. Dis. 23 , 351-361.
31. Eugenin, E.A., Eckardt, D., Theis, M., Willecke, K., Bennett, M.V., and Saez, J.C. (2001). Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-βand tumor necrosis factor-β. Proc. Natl. Acad. Sci. USA 98 , 4190-4195.
32. Evans, W.H., De Vuyst, E., and Leybaert, L. (2006). The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem. J. 397 , 1-14.
33. Facchinetti, F., Del Giudice, E., Furegato, S., Passarotto, M., and Leon, A. (2003). Cannabinoids ablate release of TNF βin rat microglial cells stimulated with lypopolysaccharide. Glia 41 , 161-168.
34. Farahani, R., Pina-Benabou, M.H., Kyrozis, A., Siddiq, A., Barradas, P.C., Chiu, F.C., Cavalcante, L.A., Lai, J.C., Stanton, P.K., and Rozental, R. (2005). Alterations in metabolism and gap junction expression may determine the role of astrocytes as "good samaritans" or executioners. Glia 50 , 351-361.
35. Ferrari, D., Chiozzi, P., Falzoni, S., Hanau, S., and Di Virgilio, F. (1997). Purinergic modulation of interleukin-1 βrelease from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185 , 579-582.
36. Froger, N., Orellana, J.A., Cohen-Salmon, M., Ezan, P., Amigou, E., Sáez, J.C., and Giaume, C. (2009). Cannabinoids prevent the opposite regulation of astroglial connexin43 hemichannels and gap junction channels induced by pro-inflammatory treatments. J. Neurochem. 111 , 1383-1397.
37. Froger, N., Orellana, J.A., Calvo, C.F., Amigou, E., Kozoriz, M.G., Naus, C.C., Sáez, J.C., and Giaume, C. (2010). Inhibition of cytokine-induced connexin43 hemichannel activity in astrocytes is neuroprotective. Mol. Cell. Neurosci. 45 , 37-46.
38. Garg, S., Md Syed, M., and Kielian, T. (2005). Staphylococcus aureus-derived peptidoglycan induces Cx43 expression and functional gap junction intercellular communication in microglia. J. Neurochem. 95 , 475-483.
39. Garre, J.M., Retamal, M.A., Cassina, P., Barbeito, L., Bukauskas, F.F., Saez, J.C., Bennett, M.V., and Abudara, V. (2010). FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels. Proc. Natl. Acad. Sci. USA 107 , 22659-22664.
40. Geula, C., Wu, C.K., Saroff, D., Lorenzo, A., Yuan, M., and Yankner, B.A. (1998). Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat. Med. 4 , 827-831.
41. Giaume, C. and Theis, M. (2010). Pharmacological and genetic approaches to study connexin-mediated channels in glial cells of the central nervous system. Brain Res. Rev. 63 , 160-176.
42. Giaume, C., Koulakoff, A., Roux, L., Holcman, D., and Rouach, N. (2010). Astroglial networks: a step further in neuroglial and gliovascular interactions. Nat. Rev. Neurosci. 11 , 87-99.
43. Glezer, I., Simard, A.R., and Rivest, S. (2007). Neuroprotective role of the innate immune system by microglia. Neuroscience 147 , 867-883.
44. Gourine, A.V., Kasymov, V., Marina, N., Tang, F., Figueiredo, M.F., Lane, S., Teschemacher, A.G., Spyer, K.M., Deisseroth, K., and Kasparov, S. (2010). Astrocytes control breathing through pHdependent release of ATP. Science 329 , 571-575.
45. Grathwohl, S.A., Kalin, R.E., Bolmont, T., Prokop, S., Winkelmann, G., Kaeser, S.A., Odenthal, J., Radde, R., Eldh, T., Gandy, S., et al. (2009). Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia. Nat. Neurosci. 12 , 1361-1363.
46. Gründken, C., Hanske, J., Wengel, S., Reuter, W., Abdulazim, A., Shestopalov, V.I., Dermietzel, R., Zoidl, G., and Prochnow, N. (2011). Unified patch clamp protocol for the characterization of Pannexin 1 channels in isolated cells and acute brain slices. J. Neurosci. Methods 199 , 15-25.
47. Halaszovich, C.R., Zitt, C., Jungling, E., and Luckhoff, A. (2000). Inhibition of TRP3 channels by lanthanides. Block from the cytosolic side of the plasma membrane. J. Biol. Chem. 275 , 37423-37428.
48. Hanisch, U.K. and Kettenmann, H. (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10 , 1387-1394.
49. Harry, G.J., Lefebvre d'Hellencourt, C., Bruccoleri, A., and Schmechel, D. (2000). Age-dependent cytokine responses: trimethyltin hippocampal injury in wild-type, APOE knockout, and APOE4 mice. Brain Behav. Immun. 14 , 288-304.
50. Henneberger, C., Papouin, T., Oliet, S.H., and Rusakov, D.A. (2010). Long-term potentiation depends on release of d-serine from astrocytes. Nature 463 , 232-236.
51. Herrera-Molina, R. and von Bernhardi, R. (2005). Transforming growth factor-β1 produced by hippocampal cells modulates microglial reactivity in culture. Neurobiol. Dis. 19 , 229-236.
52. Hofer, A. and Dermietzel, R. (1998). Visualization and functional blocking of gap junction hemichannels (connexons) with antibodies against external loop domains in astrocytes. Glia 24 , 141-154.
53. Iglesias, R., Dahl, G., Qiu, F., Spray, D.C., and Scemes, E. (2009). Pannexin 1: the molecular substrate of astrocyte "hemichannels" . J. Neurosci. 29 , 7092-7097.
54. Ishikawa, M., Iwamoto, T., Nakamura, T., Doyle, A., Fukumoto, S., and Yamada, Y. (2011). Pannexin 3 functions as an ER Ca 2 + channel, hemichannel, and gap junction to promote osteoblast differentiation. J. Cell Biol. 193 , 1257-1274.
55. Jiang, S., Yuan, H., Duan, L., Cao, R., Gao, B., Xiong, Y.F., and Rao, Z.R. (2011). Glutamate release through connexin 43 by cultured astrocytes in a stimulated hypertonicity model. Brain Res. 1392 , 8-15.
56. Kagansky, N., Levy, S., and Knobler, H. (2001). The role of hyperglycemia in acute stroke. Arch. Neurol. 58 , 1209-1212.
57. Kang, J., Kang, N., Lovatt, D., Torres, A., Zhao, Z., Lin, J., and Nedergaard, M. (2008). Connexin 43 hemichannels are permeable to ATP. J. Neurosci. 28 , 4702-4711.
58. Karpuk, N., Burkovetskaya, M., Fritz, T., Angle, A., and Kielian, T. (2011). Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity. J. Neurosci. 31 , 414-425.
59. Kawamura, M. Jr., Ruskin, D.N., and Masino, S.A. (2010). Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels. J. Neurosci. 30 , 3886-3895.
60. Keilhoff, G., Langnaese, K., Wolf, G., and Fansa, H. (2007). Inhibiting effect of minocycline on the regeneration of peripheral nerves. Dev. Neurobiol. 67 , 1382-1395.
61. Kim, J.E. and Kang, T.C. (2011). The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J. Clin. Invest. 121 , 2037-2047.
62. Kirchhoff, F., Dringen, R., and Giaume, C. (2001). Pathways of neuron-astrocyte interactions and their possible role in neuroprotection. Eur. Arch. Psychiatry Clin. Neurosci. 251 , 159-169.
63. Klein, T.W. (2005). Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 5 , 400-411.
64. Klein, T.W., Newton, C., Larsen, K., Lu, L., Perkins, I., Nong, L., and Friedman, H. (2003). The cannabinoid system and immune modulation. J. Leukoc. Biol. 74 , 486-496.
65. Knopman, D.S., Parisi, J.E., Salviati, A., Floriach-Robert, M., Boeve, B.F., Ivnik, R.J., Smith, G.E., Dickson, D.W., Johnson, K.A., Petersen, L.E., et al. (2003). Neuropathology of cognitively normal elderly. J. Neuropathol. Exp. Neurol. 62 , 1087-1095.
66. Lee, H.G., Ueda, M., Zhu, X., Perry, G., and Smith, M.A. (2006). Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-βpathway ? J. Neurosci. Res. 84 , 1856-1861.
67. Leung, D.S., Unsicker, K., and Reuss, B. (2002). Expression and developmental regulation of gap junction connexins cx26, cx32, cx43 and cx45 in the rat midbrain-floor. Int. J. Dev. Neurosci. 20 , 63-75.
68. Li, Y., Liu, L., Barger, S.W., and Griffin, W.S. (2003). Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 23 , 1605-1611.
69. Lin, J.H., Lou, N., Kang, N., Takano, T., Hu, F., Han, X., Xu, Q., Lovatt, D., Torres, A., Willecke, K., et al. (2008). A central role of connexin 43 in hypoxic preconditioning. J. Neurosci. 28 , 681-695.
70. Liu, T. and Feng, X.H. (2010). Regulation of TGF-βsignalling by protein phosphatases. Biochem. J. 430 , 191-198.
71. Locovei, S., Wang, J., and Dahl, G. (2006). Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett. 580 , 239-244.
72. Lyman, W.D., Sonett, J.R., Brosnan, C.F., Elkin, R., and Bornstein, M.B. (1989). Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J. Neuroimmunol. 23 , 73-81.
73. MacVicar, B.A. and Thompson, R.J. (2010). Non-junction functions of pannexin-1 channels. Trends Neurosci. 33 , 93-102.
74. Madry, C., Haglerod, C., and Attwell, D. (2010). The role of pannexin hemichannels in the anoxic depolarization of hippocampal pyramidal cells. Brain 133 , 3755-3763.
75. Maezawa, I., Swanberg, S., Harvey, D., LaSalle, J.M., and Jin, L.W. (2009). Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J. Neurosci. 29 , 5051-5061.
76. Malarkey, E.B. and Parpura, V. (2008). Mechanisms of glutamate release from astrocytes. Neurochem. Int. 52 , 142-154.
77. Malm, T.M., Koistinaho, M., Parepalo, M., Vatanen, T., Ooka, A., Karlsson, S., and Koistinaho, J. (2005). Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol. Dis. 18 , 134-142.
78. Malm, T.M., Magga, J., Kuh, G.F., Vatanen, T., Koistinaho, M., and Koistinaho, J. (2008). Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease. Glia 56 , 1767-1779.
79. Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., and Kivipelto, M. (2010). Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 9 , 702-716.
80. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 , 677-686.
81. Matute, C., Torre, I., Perez-Cerda, F., Perez-Samartin, A., Alberdi, E., Etxebarria, E., Arranz, A.M., Ravid, R., Rodriguez-Antiguedad, A., Sanchez-Gomez, M., et al. (2007). P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci. 27 , 9525-9533.
82. Maysinger, D., Behrendt, M., Lalancette-Hebert, M., and Kriz, J. (2007). Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles. Nano Lett. 7 , 2513-2520.
83. Meme, W., Calvo, C.F., Froger, N., Ezan, P., Amigou, E., Koulakoff, A., and Giaume, C. (2006). Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by β-amyloid. FASEB J. 20 , 494-496.
84. Molina-Holgado, F., Molina-Holgado, E., Guaza, C., and Rothwell, N.J. (2002). Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. J. Neurosci. Res. 67 , 829-836.
85. Morgan, D. (2006). Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice. Neurochem. Int. 49 , 190-194.
86. Morgan, D., Gordon, M.N., Tan, J., Wilcock, D., and Rojiani, A.M. (2005). Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J. Neuropathol. Exp. Neurol. 64 , 743-753.
87. Morita, M., Saruta, C., Kozuka, N., Okubo, Y., Itakura, M., Takahashi, M., and Kudo, Y. (2007). Dual regulation of astrocyte gap junction hemichannels by growth factors and a pro-inflammatory cytokine via the mitogen-activated protein kinase cascade. Glia 55 , 508-515.
88. Mosser, D.M. and Edwards, J.P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8 , 958-969.
89. Motta, M., Imbesi, R., Di Rosa, M., Stivala, F., and Malaguarnera, L. (2007). Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol. Lett. 114 , 46-51.
90. Nadarajah, B., Jones, A.M., Evans, W.H., and Parnavelas, J.G. (1997). Differential expression of connexins during neocortical development and neuronal circuit formation. J. Neurosci. 17 , 3096-3111.
91. Nagy, J.I., Dudek, F.E., and Rash, J.E. (2004). Update on connexins and gap junctions in neurons and glia in the mammalian nervous system. Brain Res. Brain Res. Rev. 47 , 191-215.
92. Nakase, T. and Naus, C.C. (2004). Gap junctions and neurological disorders of the central nervous system. Biochim. Biophys. Acta 1662 , 149-158.
93. Noda, M., Nakanishi, H., and Akaike, N. (1999). Glutamate release from microglia via glutamate transporter is enhanced by amyloid-βpeptide. Neuroscience 92 , 1465-1474.
94. Obregon, D., Hou, H., Bai, Y., Nikolic, W.V., Mori, T., Luo, D., Zeng, J., Ehrhart, J., Fernandez, F., Morgan, D., et al. (2008). CD40L disruption enhances A βvaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation. Neurobiol. Dis. 29 , 336-353.
95. Ohbuchi, T., Yokoyama, T., Saito, T., Ohkubo, J., Suzuki, H., Ishikura, T., Katoh, A., Fujihara, H., Hashimoto, H., and Ueta, Y. (2011). Possible contribution of pannexin channel to ATP-induced currents in vitro in vasopressin neurons isolated from the rat supraoptic nucleus. Brain Res. 1394 , 71-78.
96. Orellana, J.A., Sáez, P.J., Shoji, K.F., Schalper, K.A., Palacios-Prado, N., Velarde, V., Giaume, C., Bennett, M.V., and Sáez, J.C. (2009). Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid. Redox Signal. 11 , 369-399.
97. Orellana, J.A., Hernandez, D.E., Ezan, P., Velarde, V., Bennett, M.V., Giaume, C., and Sáez, J.C. (2010). Hypoxia in high glucose followed by reoxygenation in normal glucose reduces the viability of cortical astrocytes through increased permeability of connexin 43 hemichannels. Glia 58 , 329-343.
98. Orellana, J.A., Figueroa, X.F., Sánchez, H.A., Contreras-Duarte, S., Velarde, V., and Sáez, J.C. (2011a). Hemichannels in the neurovascular unit and white matter under normal and inflamed conditions. CNS Neurol. Disord. Drug Targets 10 , 404-414.
99. Orellana, J.A., Froger, N., Ezan, P., Jiang, J.X., Bennett, M.V., Naus, C.C., Giaume, C., and Sáez, J.C. (2011b). ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J. Neurochem. 118 , 826-840.
100. Orellana, J.A., Shoji, K.F., Abudara, V., Ezan, P., Amigou, E., Sáez, P.J., Jiang, J.X., Naus, C.C., Sáez, J.C., and Giaume, C. (2011c). Amyloid β-induced death in neurons involves glial and neuronal hemichannels. J. Neurosci. 31 , 4962-4977.
101. Ortega-Gutierrez, S., Molina-Holgado, E., and Guaza, C. (2005). Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. Glia 52 , 163-168.
102. Pacher, P., Batkai, S., and Kunos, G. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58 , 389-462.
103. Paglinawan, R., Malipiero, U., Schlapbach, R., Frei, K., Reith, W., and Fontana, A. (2003). TGF βdirects gene expression of activated microglia to an anti-inflammatory phenotype strongly focusing on chemokine genes and cell migratory genes. Glia 44 , 219-231.
104. Panchin, Y., Kelmanson, I., Matz, M., Lukyanov, K., Usman, N., and Lukyanov, S. (2000). A ubiquitous family of putative gap junction molecules. Curr. Biol. 10 , R473-474.
105. Pinteaux-Jones, F., Sevastou, I.G., Fry, V.A., Heales, S., Baker, D., and Pocock, J.M. (2008). Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. J. Neurochem. 106 , 442-454.
106. Potter, E.G., Cheng, Y., and Natale, J.E. (2009). Deleterious effects of minocycline after in vivo target deprivation of thalamocortical neurons in the immature, metallothionein-deficient mouse brain. J. Neurosci. Res. 87 , 1356-1368.
107. Puffenbarger, R.A., Boothe, A.C., and Cabral, G.A. (2000). Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia 29 , 58-69.
108. Qiu, F. and Dahl, G. (2009). A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. Am. J. Physiol. Cell Physiol. 296 , C250-C255.
109. Rakover, I., Arbel, M., and Solomon, B. (2007). Immunotherapy against APP fi-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain A βlevels. Neurodegener. Dis. 4 , 392-402.
110. Ramirez, G., Toro, R., Dobeli, H., and von Bernhardi, R. (2005). Protection of rat primary hippocampal cultures from A βcytotoxicity by pro-inflammatory molecules is mediated by astrocytes. Neurobiol. Dis. 19 , 243-254.
111. Ramirez, G., Rey, S., and von Bernhardi, R. (2008). Proinflammatory stimuli are needed for induction of microglial cell-mediated AbetaPP-{244-C} and A β-neurotoxicity in hippocampal cultures. J. Alzheimers Dis. 15 , 45-59.
112. Rana, S. and Dringen, R. (2007). Gap junction hemichannel-mediated release of glutathione from cultured rat astrocytes. Neurosci. Lett. 415 , 45-48.
113. Ransohoff, R.M. and Cardona, A.E. (2010). The myeloid cells of the central nervous system parenchyma. Nature 468 , 253-262.
114. Ray, A., Zoidl, G., Weickert, S., Wahle, P., and Dermietzel, R. (2005). Site-specific and developmental expression of pannexin1 in the mouse nervous system. Eur. J. Neurosci. 21 , 3277-3290.
115. Retamal, M.A., Froger, N., Palacios-Prado, N., Ezan, P., Sáez, P.J., Sáez, J.C., and Giaume, C. (2007). Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J. Neurosci. 27 , 13781-13792.
116. Rogers, J., Strohmeyer, R., Kovelowski, C.J., and Li, R. (2002). Microglia and inflammatory mechanisms in the clearance of amyloid βpeptide. Glia 40 , 260-269.
117. Rota, E., Bellone, G., Rocca, P., Bergamasco, B., Emanuelli, G., and Ferrero, P. (2006). Increased intrathecal TGF-β1, but not IL-12, IFN-βand IL-10 levels in Alzheimer's disease patients. Neurol. Sci. 27 , 33-39.
118. Sáez, J.C., Berthoud, V.M., Brañes, M.C., Martinéz, A.D., and Beyer, E.C. (2003). Plasma membrane channels formed by connexins: their regulation and functions. Physiol. Rev. 83 , 1359-1400.
119. Sáez, J.C., Schalper, K.A., Retamal, M.A., Orellana, J.A., Shoji, K.F., and Bennett, M.V. (2010). Cell membrane permeabilization via connexin hemichannels in living and dying cells. Exp. Cell Res. 316 , 2377-2389.
120. Salio, C., Doly, S., Fischer, J., Franzoni, M.F., and Conrath, M. (2002). Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord. Neurosci. Lett. 329 , 13-16.
121. Saud, K., Herrera-Molina, R., and von Bernhardi, R. (2005). Pro-and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells. Neurotox. Res. 8 , 277-287.
122. Schalper, K.A., Palacios-Prado, N., Orellana, J.A., and Sáez, J.C. (2008a). Currently used methods for identification and characterization of hemichannels. Cell Commun. Adhes. 15 , 207-218.
123. Schalper, K.A., Palacios-Prado, N., Retamal, M.A., Shoji, K.F., Martinez, A.D., and Sáez, J.C. (2008b). Connexin hemichannel composition determines the FGF-1-induced membrane permeability and free [Ca 2 + ] i responses. Mol. Biol. Cell 19 , 3501-3513.
124. Schalper, K.A., Sánchez, H.A., Lee, S.C., Altenberg, G.A., Nathanson, M.H., and Sáez, J.C. (2010). Connexin 43 hemichannels mediate the Ca 2 + influx induced by extracellular alkalinization. Am. J. Physiol. Cell Physiol. 299 , C1504-C1515.
125. Schock, S.C., Leblanc, D., Hakim, A.M., and Thompson, C.S. (2008). ATP release by way of connexin 36 hemichannels mediates ischemic tolerance in vitro . Biochem. Biophys. Res. Commun. 368 , 138-144.
126. Sheng, J.G., Mrak, R.E., and Griffin, W.S. (1997). Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. 94 , 1-5.
127. Sheng, W.S., Hu, S., Min, X., Cabral, G.A., Lokensgard, J.R., and Peterson, P.K. (2005). Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1 β-stimulated human astrocytes. Glia 49 , 211-219.
128. Sheng, W.S., Hu, S., Ni, H.T., Rock, R.B., and Peterson, P.K. (2009). WIN55,212-2 inhibits production of CX3CL1 by human astrocytes: involvement of p38 MAP kinase. J. Neuroimmune Pharmacol. 4 , 244-248.
129. Shie, F.S., Nivison, M., Hsu, P.C., and Montine, T.J. (2009). Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor β. Curr. Med. Chem. 16 , 643-651.
130. Sierra, A., Gottfried-Blackmore, A.C., McEwen, B.S., and Bulloch, K. (2007). Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55 , 412-424.
131. Silverman, W.R., de Rivero Vaccari, J.P., Locovei, S., Qiu, F., Carlsson, S.K., Scemes, E., Keane, R.W., and Dahl, G. (2009). The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J. Biol. Chem. 284 , 18143-18151.
132. Simard, A.R. and Rivest, S. (2006). Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. Mol. Psychiatry 11 , 327-335.
133. Simard, A.R., Soulet, D., Gowing, G., Julien, J.P., and Rivest, S. (2006). Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 , 489-502.
134. Smits, H.A., van Beelen, A.J., de Vos, N.M., Rijsmus, A., van der Bruggen, T., Verhoef, J., van Muiswinkel, F.L., and Nottet, H.S. (2001). Activation of human macrophages by amyloid-βis attenuated by astrocytes. J. Immunol. 166 , 6869-6876.
135. Sohl, G. and Willecke, K. (2004). Gap junctions and the connexin protein family. Cardiovasc. Res. 62 , 228-232.
136. Stella, N. (2004). Cannabinoid signaling in glial cells. Glia 48 , 267-277.
137. Stella, N. (2009). Endocannabinoid signaling in microglial cells. Neuropharmacology 56 (Suppl 1), 244-253.
138. Stout, C. and Charles, A. (2003). Modulation of intercellular calcium signaling in astrocytes by extracellular calcium and magnesium. Glia 43 , 265-273.
139. Stout, C.E., Costantin, J.L., Naus, C.C., and Charles, A.C. (2002). Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J. Biol. Chem. 277 , 10482-10488.
140. Stridh, M.H., Tranberg, M., Weber, S.G., Blomstrand, F., and Sandberg, M. (2008). Stimulated efflux of amino acids and glutathione from cultured hippocampal slices by omission of extracellular calcium: likely involvement of connexin hemichannels. J. Biol. Chem. 283 , 10347-10356.
141. Stridh, M.H., Correa, F., Nodin, C., Weber, S.G., Blomstrand, F., Nilsson, M., and Sandberg, M. (2010). Enhanced glutathione efflux from astrocytes in culture by low extracellular Ca 2 + and curcumin. Neurochem. Res. 35 , 1231-1238.
142. Suadicani, S.O., Brosnan, C.F., and Scemes, E. (2006). P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca 2 + signaling. J. Neurosci. 26 , 1378-1385.
143. Szydlowska, K. and Tymianski, M. (2010). Calcium, ischemia and excitotoxicity. Cell Calcium 47 , 122-129.
144. Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., and Suzumura, A. (2006). Tumor necrosis factor-βinduces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 281 , 21362-21368.
145. Takeuchi, H., Mizoguchi, H., Doi, Y., Jin, S., Noda, M., Liang, J., Li, H., Zhou, Y., Mori, R., Yasuoka, S., et al. (2011). Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease. PLoS One 6 , e21108.
146. Thompson, R.J., Zhou, N., and MacVicar, B.A. (2006). Ischemia opens neuronal gap junction hemichannels. Science 312 , 924-927.
147. Thompson, R.J., Jackson, M.F., Olah, M.E., Rungta, R.L., Hines, D.J., Beazely, M.A., MacDonald, J.F., and MacVicar, B.A. (2008). Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus. Science 322 , 1555-1559.
148. Townsend, K.P., Town, T., Mori, T., Lue, L.F., Shytle, D., Sanberg, P.R., Morgan, D., Fernandez, F., Flavell, R.A., and Tan, J. (2005). CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid β-peptide. Eur. J. Immunol. 35 , 901-910.
149. Verderio, C. and Matteoli, M. (2001). ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-β. J. Immunol. 166 , 6383-6391.
150. Vereyken, E.J., Heijnen, P.D., Baron, W., de Vries, E.H., Dijkstra, C.D., and Teunissen, C.E. (2011). Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types. J. Neuroinflammation 8 , 58.
151. Verkhratsky, A. and Toescu, E.C. (2006). Neuronal-glial networks as substrate for CNS integration. J. Cell. Mol. Med. 10 , 826-836.
152. Vogt, A., Hormuzdi, S.G., and Monyer, H. (2005). Pannexin1 and Pannexin2 expression in the developing and mature rat brain. Brain Res. Mol. Brain Res. 141 , 113-120.
153. Volterra, A. and Meldolesi, J. (2005). Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6 , 626-640.
154. von Bernhardi, R. and Eugenin, J. (2004). Microglial reactivity to β-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res. 1025 , 186-193.
155. von Bernhardi, R. and Ramirez, G. (2001). Microglia-astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system ? Biol. Res. 34 , 123-128.
156. von Bernhardi, R., Ramirez, G., Toro, R., and Eugenin, J. (2007). Pro-inflammatory conditions promote neuronal damage mediated by amyloid precursor protein and decrease its phagocytosis and degradation by microglial cells in culture. Neurobiol. Dis. 26 , 153-164.
157. von Bernhardi, R., Tichauer, J.E., and Eugenin, J. (2010). Agingdependent changes of microglial cells and their relevance for neurodegenerative disorders. J. Neurochem. 112 , 1099-1114.
158. von Bernhardi, R., Tichauer, J., and Eugenin-von Bernhardi, L. (2011). Proliferating culture of aged microglia for the study of neurodegenerative diseases. J. Neurosci. Methods 202 , 65-69.
159. Waksman, Y., Olson, J.M., Carlisle, S.J., and Cabral, G.A. (1999). The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J. Pharmacol. Exp. Ther. 288 , 1357-1366.
160. Walter, L. and Stella, N. (2004). Cannabinoids and neuroinflammation. Br. J. Pharmacol. 141 , 775-785.
161. Wang, J., Ma, M., Locovei, S., Keane, R.W., and Dahl, G. (2007). Modulation of membrane channel currents by gap junction protein mimetic peptides: size matters. Am. J. Physiol. Cell Physiol. 293 , C1112-C1119.
162. Wegiel, J., Wang, K.C., Tarnawski, M., and Lach, B. (2000). Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta Neuropathol. 100 , 356-364.
163. Wilcock, D.M., DiCarlo, G., Henderson, D., Jackson, J., Clarke, K., Ugen, K.E., Gordon, M.N., and Morgan, D. (2003). Intracranially administered anti-A βantibodies reduce β-amyloid deposition by mechanisms both independent of and associated with microglial activation. J. Neurosci. 23 , 3745-3751.
164. Wu, S.Z., Bodles, A.M., Porter, M.M., Griffin, W.S., Basile, A.S., and Barger, S.W. (2004). Induction of serine racemase expression and d-serine release from microglia by amyloid β-peptide. J. Neuroinflammation 1 , 2.
165. Yang, Y., Ge, W., Chen, Y., Zhang, Z., Shen, W., Wu, C., Poo, M., and Duan, S. (2003). Contribution of astrocytes to hippocampal longterm potentiation through release of d-serine. Proc. Natl. Acad. Sci. USA 100 , 15194-15199.
166. Ye, Z.C., Wyeth, M.S., Baltan-Tekkok, S., and Ransom, B.R. (2003). Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J. Neurosci. 23 , 3588-3596.
167. Ye, Z.C., Oberheim, N., Kettenmann, H., and Ransom, B.R. (2009). Pharmacological "cross-inhibition" of connexin hemichannels and swelling activated anion channels. Glia 57 , 258-269.
168. Zappala, A., Cicero, D., Serapide, M.F., Paz, C., Catania, M.V., Falchi, M., Parenti, R., Panto, M.R., La Delia, F., and Cicirata, F. (2006). Expression of pannexin1 in the CNS of adult mouse: cellular localization and effect of 4-aminopyridine-induced seizures. Neuroscience 141 , 167-178.
169. Zappala, A., Li Volti, G., Serapide, M.F., Pellitteri, R., Falchi, M., La Delia, F., Cicirata, V., and Cicirata, F. (2007). Expression of pannexin2 protein in healthy and ischemized brain of adult rats. Neuroscience 148 , 653-667.
170. Zhang, L., Deng, T., Sun, Y., Liu, K., Yang, Y., and Zheng, X. (2008). Role for nitric oxide in permeability of hippocampal neuronal hemichannels during oxygen glucose deprivation. J. Neurosci. Res. 86 , 2281-2291.
171. Zhu, X., Raina, A.K., Perry, G., and Smith, M.A. (2004). Alzheimer's disease: the two-hit hypothesis. Lancet Neurol. 3 , 219-226.
172. Zhu, Y., Yang, G.Y., Ahlemeyer, B., Pang, L., Che, X.M., Culmsee, C., Klumpp, S., and Krieglstein, J. (2002). Transforming growth factor-β1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22 , 3898-3909.
173. Zurier, R.B. (2003). Prospects for cannabinoids as anti-inflammatory agents. J. Cell. Biochem. 88 , 462-466.